Chimerix (CMRX)

Add to Watchlists
Create an Alert
20.44 +1.20  +6.24% NASDAQ Apr 17, 4:59PM BATS Real time Currency in USD
View Full Chart
CMRX Price Chart
View All Performance Charts

CMRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Chimerix is up 6.18% over the last year vs S&P 500 Total Return up 20.96%, Alexion Pharmaceuticals up 55.82%, and Actelion up 66.30%.

Get Quote for

PDF Report for CMRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download CMRX Pro Report PDF

Portfolio Strategies Featuring CMRX

Did Chimerix make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CMRX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: North Carolina
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Chimerix Inc is a biopharmaceutical company discovering, developing and commercializing novel, oral antiviral therapeutics that are designed to transform patient care in areas of high unmet medical needs.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CMRX 20.44 +1.20 +6.24% 547.03M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.